Dissecting Microenvironmental Interactions in Pediatric High-Grade Gliomas that Promote Tumor Growth |
Dana-Farber Cancer Institute / Mariella G. Filbin, MD/PhD |
Crazy 8 Pilots |
2019 |
Massachusetts |
Selectively targeting EP300 with small molecules for neuroblastoma (NB) therapy |
Dana-Farber Cancer Institute / Jun Qi, PhD |
Innovation Grants |
2019 |
Massachusetts |
Predicting and Overcoming Resistance to Immunotherapy in Pediatric High-Grade Glioma |
Ann & Robert H. Lurie Children’s Hospital of Chicago / Oren Becher, MD & Robert Wechsler-Reya, PhD |
Innovation Grants |
2019 |
Illinois |
Targeting mechanisms of Siglec15-mediated immune evasion in hematologic malignancies |
Emory University / Christopher Porter, MD |
Innovation Grants |
2019 |
Georgia |
The anti-tumor immune microenvironment in the Sonic Hedgehog subclass of medulloblastoma |
Emory University / Anna Kenney, PhD |
Innovation Grants |
2019 |
Georgia |
The use of hematopoietic stem and progenitor cells to reverse treatment resistance to PD-1 blockade |
University of Florida / Catherine Flores, PhD |
Innovation Grants |
2019 |
Florida |
Single Cell RNA Sequencing of Pediatric High- and Low-Grade Gliomas |
University of Colorado Denver / Adam Green, MD and Jean Mulcahy Levy, MD |
Single-cell Pediatric Cancer Atlas Grant |
2019 |
Colorado |
Live-Cell Surface Proteomic Characterization of Atypical Teratoid Rhabdoid Tumors Using High Throughout Multi-Color Flow |
University of Colorado Denver / Siddhartha S. Mitra, PhD |
Crazy 8 Pilots |
2019 |
Colorado |
Preclinical Development of a First-in-Class PCNA Inhibitor for Treating Neuroblastoma |
City of Hope National Medical Center / Linda Malkas, PhD |
Reach Grants |
2019 |
California |
Intervention Development and Evaluation to Reduce Disparities in Quality of Life for Latino Families Impacted by Cancer |
The Regents of the University of California, Irvine / Michelle Fortier, PhD |
Psychosocial Family Impact Grant |
2019 |
California |